Literature DB >> 7650462

Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.

T Lancaster1, G Surman, M Lawrence, D Mant, M Vessey, M Thorogood, P Yudkin, E Daly.   

Abstract

STUDY
OBJECTIVE: To assess the feasibility of recruiting a cohort of women, including long term users of postmenopausal hormone replacement therapy (HRT), through computerised general practice prescribing records, and to compare clinical and demographic characteristics of users and non-user controls.
DESIGN: Cross sectional analysis of questionnaire data.
SETTING: Subjects were recruited through 17 general practices in the Oxfordshire, south west Thames, and north west Thames regions that contributed to the VAMP Research Database. PARTICIPANTS: A total of 2964 women aged 45-64 years were identified. Altogether 1482 were long term (> 1 year) users of HRT and 1482 were non-user controls: 1037 (70%) of the users and 819 (55.3%) of the controls agreed to participate and provided questionnaire data. MAIN
RESULTS: Users of HRT were more likely to have undergone hysterectomy than controls. Most women with a history of hysterectomy used unopposed oestrogen, while those with intact uteri generally used a combination of oestrogen and a progestagen. Among women who had undergone hysterectomy, HRT users did not differ significantly from controls over a range of demographic and clinical characteristics but they were more likely to be past users of oral contraceptives. Among women with intact uteri, users were similar to controls in terms of reported clinical characteristics, but were of higher social class and were more likely to be past users of oral contraceptives and to have had a mammogram after the age of 50. Compared with the general population, all categories of women recruited to the study were of higher social class and exhibited more health conscious behaviours.
CONCLUSIONS: Electronic general practice prescribing records provide a feasible and efficient method for recruiting women to a cohort of HRT. Women who agreed to participate in this study were not representative of the general population, emphasising the importance of internal controls in such a study. Among participants, HRT users who had not undergone hysterectomy showed evidence of better health than non-users on some dimensions. In the whole sample, however, there were no appreciable differences in social class and self reported health indicators between users and controls.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650462      PMCID: PMC1060127          DOI: 10.1136/jech.49.4.389

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  23 in total

1.  The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.

Authors:  S G Thompson; T W Meade; G Greenberg
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

2.  Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community.

Authors:  M H Criqui; L Suarez; E Barrett-Connor; J McPhillips; D L Wingard; C Garland
Journal:  Am J Epidemiol       Date:  1988-09       Impact factor: 4.897

3.  Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms.

Authors:  G Greenberg; S G Thompson; T W Meade
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

4.  Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities.

Authors:  C A Derby; A L Hume; M M Barbour; J B McPhillips; T M Lasater; R A Carleton
Journal:  Am J Epidemiol       Date:  1993-05-15       Impact factor: 4.897

5.  Magnitude and causes of socioeconomic differentials in mortality: further evidence from the Whitehall Study.

Authors:  G D Smith; M J Shipley; G Rose
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

6.  Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy.

Authors:  K Hunt; M Vessey; K McPherson; M Coleman
Journal:  Br J Obstet Gynaecol       Date:  1987-07

7.  Effects of long-term estrogen replacement therapy. I. Metabolic effects.

Authors:  C B Hammond; F R Jelovsek; K L Lee; W T Creasman; R T Parker
Journal:  Am J Obstet Gynecol       Date:  1979-03-01       Impact factor: 8.661

8.  Estrogen replacement therapy and protection from acute myocardial infarction.

Authors:  B E Henderson; A Paganini-Hill; R K Ross
Journal:  Am J Obstet Gynecol       Date:  1988-08       Impact factor: 8.661

9.  Mortality decline and widening social inequalities.

Authors:  M G Marmot; M E McDowall
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

10.  Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort.

Authors:  P H Wolf; J H Madans; F F Finucane; M Higgins; J C Kleinman
Journal:  Am J Obstet Gynecol       Date:  1991-02       Impact factor: 8.661

View more
  5 in total

1.  Why do women doctors in the UK take hormone replacement therapy?

Authors:  A J Isaacs; A R Britton; K McPherson
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

2.  Is there sufficient evidence for us to encourage the widespread use of hormone replacement therapy to prevent disease?

Authors:  P C Hannaford
Journal:  Br J Gen Pract       Date:  1998-02       Impact factor: 5.386

3.  Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Authors:  L J Lambert; J A Y Straton; M W Knuiman; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

4.  Socioeconomic status and HRT prescribing: a study of practice-level data in England.

Authors:  Sarah Hillman; Saran Shantikumar; Ali Ridha; Dan Todkill; Jeremy Dale
Journal:  Br J Gen Pract       Date:  2020-10-29       Impact factor: 5.386

5.  Comparison of various characteristics of women who do and do not attend for breast cancer screening.

Authors:  Emily Banks; Valerie Beral; Rebecca Cameron; Ann Hogg; Nicola Langley; Isobel Barnes; Diana Bull; Gillian Reeves; Ruth English; Sarah Taylor; Jon Elliman; Carole Lole Harris
Journal:  Breast Cancer Res       Date:  2001-11-06       Impact factor: 6.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.